Can Rivian meet R2 production targets? -- Citi Research
Citi Research analysts Michael Ward and Vikram Bagri initiated coverage of Rivian NASDAQ:RIVN with a Neutral rating, reflecting risks with the R2 launch and the challenges Rivian NASDAQ:RIVN faces with high-volume production.The R1S, R1T, EDV, and R2 are currently in production at Rivian’s NASDAQ:R…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.